Stock Markets February 22, 2026

European Equities Split Between Defense, Financials Rally and Consumer, Healthcare Slump

Among the 250 largest listings, miners and defense contractors top the gains while healthcare and staples names register steep declines over 12 months

By Priya Menon
European Equities Split Between Defense, Financials Rally and Consumer, Healthcare Slump

European markets in early 2026 are marked by a sharp bifurcation: defense contractors, materials names and many banks have posted triple-digit 12-month gains, while a set of consumer staples and healthcare-related stocks have fallen sharply, some losing nearly half their market value. The divergence shows up across sectors and countries and has driven meaningful fund flows, with passive inflows powering the strongest year-to-date intake for Europe-focused equity funds since 2015.

Key Points

  • Materials, defense contractors and a number of banks are among the best-performing names across the 250 largest European-listed companies, led by Fresnillo (+436.4% to 37.0p).
  • A group of consumer staples and healthcare-related stocks have fallen sharply, with Novo Nordisk down 47.9% to DKK 369.6 and several Swiss-listed firms among the larger decliners.
  • Passive fund inflows are driving a record start to the year for Europe-focused equity funds, with $21.60 billion in passive inflows offsetting $5.74 billion of active outflows and resulting in $15.86 billion year-to-date net intake.

European equities display a pronounced split in performance over the past 12 months, according to BofA Global Research’s European Snapshot. Of the 250 largest companies listed in Europe, a handful of materials and defense names have recorded exceptional returns while several consumer staples and healthcare-related firms have seen substantial declines.

Leading the gainers is Fresnillo, which rose 436.4% to 37.0p. It is followed by Nebius, up 202.2% to $85.2, and Endeavour Mining, which climbed 171.7% to 42.2p. The rally among materials and defense-related groups is notable - Rheinmetall jumped 154.0% to  1,781.5 and Siemens Energy advanced 139% to  144.6.

Financial stocks also dominate the top of the leaderboard. Société Générale surged 153.0% to  73.8, Commerzbank gained 129.6% to  34.7, Banco Santander added 125.6% to  10.8, and BBVA rose 112.1% to  21.5. A broader set of banks - ABN AMRO, CaixaBank, Deutsche Bank, Bank of Ireland, Bankinter, Standard Chartered, UniCredit, Lloyds Banking, and Prudential - recorded gains in a range roughly between 79% and 100% over the same period.

Defense-oriented names show sustained investor interest amid elevated geopolitical concerns. Swedens Saab climbed 130.0% to SEK 693.3. Rolls-Royce added 102.3% to 12.1p and Leonardo gained 89.6% to  56.3, underscoring the sector-wide strength.


At the other extreme, several large-cap European companies have declined sharply. Novo Nordisk was the weakest among the large equities, shedding 47.9% to DKK 369.6. Wolters Kluwer fell 44.9% to  78.9, Diageo dropped 36.8% to 16.8p, and Pernod Ricard declined 32.9% to  75.1.

Other notable falls include Orsted, down 32.1% to DKK 141.6; Coloplast, off 30.5% to DKK 536.0; and Sonova, down 30.1% to CHF 211.5. Switzerland-listed names figure prominently among the underperformers: DSM-Firmenich is off 29.6% to  66.2; Sika is down 24.7% to CHF 148.3; Givaudan has lost 20.7% to CHF 2,988; Partners Group is down 20.1% to CHF 1,050; Straumann fell 18.2% to CHF 93.1; and Alcon shed 17.7% to CHF 62.4.

Frances Dassault Systmes declined 28.8% to  23.2, while Germanys Adidas fell 28.6% to  149.2. Stellantis dropped 24.9% to $8.3 and Ferrari lost 22.7% to $280.8.


The divergence between winners and losers tracks broader market dynamics observed in February. Commodities-exposed stocks gained 3.3% month-to-date on a relative basis, while US-exposed stocks lost 1.7%, per the same BofA report. Discretionary names were the weakest sector in Q1 2026, declining 12.1% and trailing their historical average by 13.4 percentage points. Utilities were the strongest sector, rising 7.8% and running 9.6 percentage points above historical norms. At the country level, the Netherlands led with a 7.4% gain, putting it 6.2 points ahead of its historical trend.

Flows into the highest- and lowest-performing groups reveal investor preferences. The top-performing stocks attracted $1.67 billion in fund inflows during the month, split between $0.25 billion from active funds and $1.42 billion from passive vehicles. The lowest-performing cohort nevertheless drew $0.39 billion in net inflows, despite $0.07 billion of active outflows that were offset by $0.45 billion of passive buying.

Europe-focused equity funds have taken in $15.86 billion year-to-date, the strongest start to the year since 2015, driven entirely by passive flows of $21.60 billion while active funds experienced outflows totaling $5.74 billion. In the most recent week, net inflows reached $2.65 billion. At a sector and country level, Size stocks, Industrials and Switzerland recorded the largest inflows, while the UK and Risk stocks recorded outflows.

Market-structure indicators show a note of caution. BofAs European Momentum Conviction Indicator stood at 32 as of Feb. 19 - just above the 30 threshold that the bank identifies as a signal of elevated crash risk - and is its weakest reading since November 2025.

Overall, the BofA snapshot paints a market polarized between cyclically exposed winners and consumer- and healthcare-related laggards, with passive fund flows heavily concentrated in the positive performers and broader momentum metrics signalling a slightly heightened risk environment.

Risks

  • Momentum indicator sitting at 32 as of Feb. 19 - just above the 30 threshold that BofA associates with elevated crash risk - suggests increased short-term downside vulnerability across European equities, impacting broad market exposure.
  • Sector concentration of inflows into high-performing stocks and heavy passive buying could exacerbate divergences and increase volatility for both the winners (commodities, defense, financials) and the laggards (consumer staples, healthcare).
  • Sharp underperformance among discretionary, healthcare and Swiss-listed names introduces earnings and valuation uncertainty for portfolios with exposure to those sectors and countries.

More from Stock Markets

Nvidia Results and Software Earnings to Test AI-Driven Market Sentiment Feb 22, 2026 Analysts Shift AI Bets: Nvidia, Amazon, Dell, Analog Devices, Shopify See Upgrades and Bullish Casework Feb 22, 2026 Investors Trim Positions in EssilorLuxottica Amid Smart-Glasses Threat Feb 22, 2026 Stifel Warns Enterprise Software May Face Prolonged Realignment, Drawing Lessons from eCommerce Shift Feb 22, 2026 Chinese AI Stocks Rally as Investors Embrace Winners While U.S. Markets Worry Feb 21, 2026